ZFP69B
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| ZFP69 zinc finger protein B | Ensembl:ENSG00000187801 | HGNC:HGNC:28053 | PA134991949 | 1p34.2 |
GO terms in ZFP69B
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| CC | IBA | GO:0005634 | nucleus |
| CC | IEA | GO:0005634 | nucleus |
| BP | IEA | GO:0006351 | transcription, DNA-templated |
| BP | IEA | GO:0006357 | regulation of transcription by RNA polymerase II |
| MF | ISA | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| MF | IEA | GO:0003677 | DNA binding |
| MF | IBA | GO:0003700 | DNA-binding transcription factor activity |
| MF | IPI | GO:0005515 | protein binding |
| MF | IBA | GO:0043565 | sequence-specific DNA binding |
| MF | IEA | GO:0046872 | metal ion binding |
Gene expression in normal tissue: ZFP69B
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in ZFP69B
| Database | Pathway ID | Pathway Des. |
|---|---|---|
| reactome | R-HSA-212436 | Generic Transcription Pathway |
| reactome | R-HSA-73857 | RNA Polymerase II Transcription |
| reactome | R-HSA-74160 | Gene expression (Transcription) |
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD268 | Cerulenin | 7 |
| iGMDRD451 | Serdemetan | 3 |
| iGMDRD524 | ISX-9 | 3 |
| iGMDRD690 | PRIMA-1MET | 5 |
| iGMDRD64 | Parbendazole | 3 |
| iGMDRD224 | Necrostatin-1 | 5 |
| iGMDRD577 | BIX01294 | 6 |
| iGMDRD562 | Navitoclax | 10 |
| iGMDRD188 | Piperlongumine | 5 |
| iGMDRD100 | Zebularine | 2 |
| iGMDRD801 | 2,4-dideoxy-DC-45-A2 | 3 |
| iGMDRD318 | PAC-1 | 5 |
| iGMDRD52 | Rotenone | 2 |
| iGMDRD171 | Pemetrexed | 2 |
| iGMDRD802 | 4-methylfasudil | 4 |
| iGMDRD513 | BML-259 | 2 |
| iGMDRD247 | Blebbistatin | 2 |
| iGMDRD634 | SCHEMBL2608041 | 7 |
| iGMDRD375 | GW-405833 | 2 |
| iGMDRD380 | Pifithrin-alpha | 4 |
| iGMDRD466 | Chaetocin | 3 |
| iGMDRD280 | CYTOCHALASIN B | 2 |
| iGMDRD446 | LY 2183240 | 7 |
| iGMDRD201 | SKI II | 3 |
| iGMDRD494 | Neopeltolide | 2 |
| iGMDRD427 | ABT737 | 9 |
| iGMDRD144 | NSC95397 | 7 |
| iGMDRD579 | PF750 | 5 |
| iGMDRD1008 | SR-II-138A | 10 |
| iGMDRD772 | BRD4770 | 5 |
| iGMDRD126 | Tipifarnib | 2 |
| iGMDRD82 | Quiflapon | 2 |
| iGMDRD147 | Prima-1 | 5 |
| iGMDRD269 | Purmorphamine | 2 |
| iGMDRD286 | Nsc 632839 | 5 |
| iGMDRD871 | BRD6368 | 2 |
| iGMDRD872 | BRD7137 | 1 |
| iGMDRD213 | SMR000068650 | 2 |
| iGMDRD6 | AM-580 | 1 |
| iGMDRD137 | Indisulam | 6 |
| iGMDRD158 | NSC141540 | 2 |
| iGMDRD154 | NSC23766 | 3 |
| iGMDRD177 | Teniposide | 3 |
| iGMDRD57 | Chloropentafluorobenzene | 6 |
| iGMDRD523 | Cyanoquinoline, 11 | 5 |
| iGMDRD584 | VER 155008 | 3 |
| iGMDRD607 | Ubistatin B | 2 |
| iGMDRD307 | Manumycin A | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in ZFP69B
CLASSFICATION
Copyright © 2018 Modellab | All Rights Reserved
Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.